Laboratory Centrifuges Patents: Leaders, Trends & White Space 2026
- 23.6% concentration at the top. The five leading assignees account for 352 of the 1,493 records in scope — a dense core surrounded by a long tail of single- and few-filing entrants.
- Filings cooled from a 2021 peak. Annual filings ran from 53 in 2021 to 28 in 2024, a -47% pull-back over that span, though 2025-2026 counts are still filling in given the usual publication lag.
- Centrifuge hardware sits behind analytical use. G01N (material analysis) appears on 38.2% of records versus 31.9% for B04B (centrifuges) itself, showing most filings frame the rotor as a means to an assay, not an end in itself.
Filing growth compares 2021 (53 records) with 2024 (28) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 1,493 records in scope (CR5), not by the ranked leaders only.
What the laboratory centrifuge patent record actually covers
The dataset spans 1,493 published records filed against claims combining core centrifuge hardware — rotors, imbalance detection, aerosol containment — with operational concerns like temperature control, cycle time and maintenance logging. This is a mature mechanical category increasingly pulled into molecular diagnostics: a large share of records cite material analysis and testing classes alongside the centrifuge class itself, reflecting how much of the recent activity is centrifugation embedded inside a diagnostic or sample-prep workflow rather than a standalone bench instrument.
Filing activity peaked in 2021 and has since eased, though the most recent years understate true activity because publication typically lags filing by around 18 months. Assignee concentration is moderate rather than extreme: the leading company holds a clear lead, but the top ten together still account for well under half of all records, leaving considerable room for smaller and newer entrants.
Filing trends and technology composition
Two views of the same 1,493-record set: how filing activity has moved year over year, and which technology classes those filings sit in.
Filing trend, 2017-2026
Annual filings rose to a peak of 53 in 2021, then declined to 28 by 2024 — a -47% move over that three-year window. Treat 2025 and 2026 figures as provisional; publication lag means recent-year counts will keep rising as more records surface.
Technology composition by IPC subclass
G01N (material analysis & testing) leads at 38.2% of the 1,493 records, ahead of B04B (centrifuges) at 31.9%, with B01L (lab apparatus), C12Q and C12N each appearing on roughly one in six records. Because records carry multiple classes, these shares sum past 100% and should be read as overlap, not a partition of the field.
Shares are the percentage of the 1,493 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Laboratory Centrifuges with Eureka
This page is one run against one query. Ask Eureka your own question about laboratory centrifuges and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited and most representative filings
US20220241800A1 — Temperature control for a centrifuge (Eppendorf SE, 2022)
A centrifuge with a rotor accommodated in a housing, plus a temperature control device using air-directing means that draw air into the centrifuge container from a lower region. The design targets more effective cooling of heat-emitting components such as the rotor and motor during operation.Abstract condensed from the original filing.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6632655B1 | Manipulation of microparticles in microfluidic systems | 982 |
| 2 | US6319469B1 | Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system | 638 |
| 3 | US6063589A | Devices and methods for using centripetal acceleration to drive fluid movement on a microfluidics system | 631 |
| 4 | WO1997021090A1 | Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system with… | 491 |
| 5 | US6303343B1 | Inefficient fast PCR | 398 |
| 6 | US20070026421A1 | Method and apparatus for generating thermal melting curves in a microfluidic device | 354 |
| 7 | US6302134B1 | Device and method for using centripetal acceleration to device fluid movement on a microfluidics system | 352 |
| 8 | US20070060872A1 | Apparatus and methods for analyzing body fluid samples | 348 |
| 9 | WO1998053311A2 | Devices and methods for using centripetal acceleration to drive fluid movement in a microfluidics system | 340 |
| 10 | US8435738B2 | Systems and methods for multi-analysis | 312 |
Citation counts favour older filings that have had more time to accumulate references — read them as a signal of influence within this corpus, not as a measure of current commercial importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three patterns stand out once the ranking, the trend and the class breakdown are read together.
The core is occupied, the edges are not
The leading five assignees hold 352 of the 1,493 records in scope, but that leaves more than three-quarters of the field spread across a long tail. A new entrant is not choosing between one dominant incumbent and open ground — they are choosing which corner of a moderately crowded field to enter.
A post-peak cool-down, not a collapse
Filings dropped from 53 in 2021 to 28 in 2024. That is a real pull-back from peak, but it follows years of elevated activity tied to diagnostic and sample-prep applications, and the most recent years are still incomplete in the published record.
Analytical framing outweighs pure hardware
More records touch material analysis and testing (G01N) than the centrifuge class itself (B04B). Claims increasingly describe the centrifuge as one step in an assay or diagnostic pipeline, which shifts where the defensible novelty sits — often in workflow integration rather than rotor mechanics alone.
US-centred, with a real European and PCT presence
The United States receives the largest single share of filings, with Europe and WIPO/PCT routes each carrying meaningful volume behind it. Japan, Canada and Australia trail but are not negligible, suggesting freedom-to-operate work should not stop at the US and EPO alone.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to laboratory centrifuges, with the prior art for and against each one.
Who is filing, and who has slowed
The ranking spans 100 companies across 1,493 records. A handful hold a clear lead; most of the rest show only occasional activity in recent years.
A clear but not dominant leader
The top-ranked assignee holds 83 records, well ahead of fifth place at 52 and tenth place at 30. That gap shows a genuine incumbent advantage, but the drop-off from first to fifth is gradual rather than a cliff.
Several established filers show no recent activity
A number of the historically largest assignees, including one filer that dropped -100% year over year, show zero filings in the latest tracked year. That is consistent with publication lag rather than necessarily exit, but it does mean recent competitive signal from these names is thin.
Collaboration is limited and concentrated
Only ten co-assignee pairs appear in the dataset, and the strongest of them cluster around a small number of related corporate entities rather than arm's-length partnerships. Most filings in this field are single-assignee.
| Assignee | Recent year | YoY |
|---|---|---|
| Theranos, Inc. | 0 | — |
| Beckman Coulter, Inc. | 0 | — |
| Medtronic, Inc. | 0 | — |
| Eppendorf AG | 0 | -100% |
| Research Development Foundation | 0 | — |
| T2 Biosystems, Inc. | 0 | — |
| Beckman Instruments, Inc. | 0 | — |
| Caliper Life Sciences, Inc. | 0 | — |
Where to take this analysis
The dataset points to a field with an occupied core and a genuinely open periphery. Turning that into a filing or freedom-to-operate decision means going deeper on the specific claim language.
Map claim language in the under-claimed branches
Imbalance detection, aerosol containment and rotor fatigue prediction show lighter filing density than core rotor and analysis claims. Before drafting, check how existing claims in adjacent classes are worded to avoid overlap.
Explore claims in EurekaTrack the recent-momentum shift
Several historically active assignees show zero filings in the latest tracked year. Confirming whether that reflects publication lag or an actual pull-back changes how much white space is really available.
Monitor assignee activity in EurekaCheck freedom to operate beyond the US and EPO
With meaningful filing volume through WIPO/PCT and a real Japan and Canada presence, a US-only clearance search will miss relevant prior art.
Run a global search in EurekaCommon questions about laboratory centrifuge patents
Across the 1,493 records in scope, one assignee leads with 83 records, ahead of the fifth-ranked company at 52 and the tenth-ranked at 30. The gap from first to fifth place is gradual rather than dominated by a single company, and the top five together account for only 23.6% of all records in scope. That means the field has a recognisable leader but no single company controls the space outright.
Filings peaked at 53 in 2021 and had fallen to 28 by 2024, a -47% change over that three-year span. However, patent publication typically lags filing by around 18 months, so 2025 and 2026 figures in any dataset will look artificially low until more records surface. The honest read is a cool-down from a 2021 peak, not a confirmed long-term decline.
Material analysis and testing (IPC class G01N) appears on 38.2% of the 1,493 records, slightly ahead of the centrifuge class itself (B04B) at 31.9%. Lab apparatus, enzyme/DNA testing and microorganism-related classes each appear on roughly one in six records. This overlap shows that a large share of centrifuge patent activity is driven by diagnostic and molecular-biology applications rather than centrifuge hardware alone.
Sub-areas like real-time rotor imbalance sensing, aerosol containment seal validation, rotor fatigue life prediction and automated maintenance-record logging show comparatively lighter filing density than the core rotor and analytical claims. These are not unclaimed, but they are less crowded than the mechanical and assay-integration claims that dominate the top of the ranking. Anyone drafting in these areas should still run a full clearance search, since density figures describe relative crowding, not absence of prior art.
The United States receives the largest share of tracked filings at 601, followed by the European Patent Office at 233 and WIPO/PCT filings at 163. Australia, Canada and Japan each carry smaller but non-trivial volumes. A clearance or landscape review limited to the US alone would miss a substantial share of the relevant filings, particularly those routed through the EPO and PCT.
Research Laboratory Centrifuges in depth with Eureka
Go past this page: query the whole laboratory centrifuges corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.